IRLAB Therapeutics – executive interview

IRLAB Therapeutics – executive interview

IRLAB Therapeutics — 5 videos in collection

More on this equity

Based in Scandinavia, IRLAB Therapeutics is dedicated to discovering and developing new drugs for treating Parkinson’s disease and other life-altering illnesses that affect the central nervous system. In this interview, IRLAB’s executive vice president and head of R&D (previously CEO) Nicholas Waters provides an update on the company’s strategy and pipeline.


You may also be interested in these:

Healthcare

IRLAB Therapeutics – executive interview

Healthcare

IRLAB Therapeutics – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free